Infectious Diseases & Vaccines
Advancing Infection Control and Immunization Through Medical Device Trials
Focus on Device Trials in Infectious Diseases
Diagnostic Devices
Point-of-care (POC) and molecular diagnostics for bacterial and viral pathogens.
Rapid antigen and PCR-based test systems for influenza, RSV, COVID-19, tuberculosis, HIV, and others.
Multiplex diagnostic platforms enabling simultaneous detection of co-infections.
Vaccine Delivery Systems
Needle-free injection systems, microneedle patches, and auto-injectors designed to improve immunization safety and compliance.
Smart cold-chain and dose-tracking devices supporting vaccine logistics.
Therapeutic and Supportive Devices
Antimicrobial and antiviral coating technologies for clinical environments.
Ventilation, oxygenation, and infection control systems for hospital and ICU use.
Wearable biosensors for infection monitoring and immune response tracking.
Digital and Connected Health Devices
Remote monitoring solutions integrating AI and data analytics for outbreak tracking.
Mobile health platforms supporting decentralized infectious disease trials.
Comprehensive Clinical Trial Services
Feasibility & Protocol Design
Study design optimization, patient population identification, and endpoint development tailored to diagnostic and therapeutic device evaluation.
Regulatory & Ethical Compliance
Navigation of Health Canada, FDA, and international device-specific regulatory frameworks (Class I–III). Preparation of Investigational Testing Authorization (ITA), IDE, and CE documentation.
Site Management & Patient Recruitment
A broad network of hospitals, clinics, and community health centers enables rapid site activation and targeted enrollment.
Performance & Usability Testing
Execution of analytical, clinical, and human factors studies for regulatory approval.
Scientific & Operational Expertise
Our Infectious Disease Device Division is led by clinical researchers, epidemiologists, and biomedical engineers experienced in device trials. This cross-functional expertise ensures a unified approach to safety, accuracy, and clinical utility.
Core Competencies:
Clinical validation of diagnostic and screening devices
Device–drug and device–vaccine interface studies
Biocompatibility, sterilization, and infection control testing
Health economics and real-world evidence (RWE) collection
Human factor engineering and usability assessment
Integrated SMO–CRO Model
At Conduct Research, we combine the capabilities of a Site Management Organization (SMO) and a Clinical Research Organization (CRO), ensuring every phase of device testing is coordinated efficiently and transparently.
Site Readiness & Investigator Support: Trained infectious disease specialists and device-focused investigators.
Data Management & Monitoring: Centralized EDC systems with remote monitoring and real-time reporting.
Quality Assurance: GCP-ISO 14155 alignment and adherence to medical device regulatory standards.
Speed & Scalability: Accelerated activation models for outbreak-response and time-critical studies.
Partner With Us
Conduct Research supports pharmaceutical, biotech, and public health organizations in advancing infectious disease and vaccine programs from concept to market.Our Commitment
Through our infectious disease and vaccine device trials, Conduct Research is advancing the next generation of technologies designed to safeguard global health.
Our approach combines clinical precision, scientific depth, and operational agility, enabling sponsors to move from concept to commercialization with confidence.
We are driven by the belief that innovation in devices is as vital as innovation in medicine—together, they define the future of infectious disease prevention, detection, and care.